![](/img/cover-not-exists.png)
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for wild-typeKRASmetastatic colorectal cancer refractory to irinotecan, oxaliplatin, and fluoropyrimidines
Kohei Shitara, Satoshi Yuki, Motoki Yoshida, Daisuke Takahari, Setsuo Utsunomiya, Tomoya Yokota, Yozo Sato, Yoshitaka Inaba, Masahiro Tajika, Hiroki Kawai, Hidekazu Yamaura, Mina Kato, Kentaro YamazakVolume:
30
Language:
english
Pages:
7
DOI:
10.1007/s10637-010-9615-z
Date:
April, 2012
File:
PDF, 144 KB
english, 2012